Markets:

Overview

News

Currencies

International

Treasuries

IGC Pharma, Inc. Common Stock (NY:IGC)

0.1873 -0.0077 (-3.95%)

Delayed Quote Updated: 10:35 AM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

IGC Pharma's Alzheimer's Agitation Drug Candidate Now Patented in the U.S., Canada, and Mexico as Phase 2 Readout Nears

Today 10:18 EST

Canada grants patent on IGC-AD1, an investigational oral therapy for agitation in Alzheimer's disease. Agitation is one of the hardest symptoms for families to manage.

From IGC Pharma, Inc.

Via ACCESS Newswire

5 Biotech Stocks’ TCRT, IGC, PDSB, PFAI, Acquisition, Alzheimer’s, Cardio and Cancer Research Milestones

October 13, 2026

Via AB Newswire

Topics Artificial Intelligence

IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment

October 13, 2026

From IGC Pharma, Inc.

Via ACCESS Newswire

4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch

October 07, 2026

Via AB Newswire

Topics Animal Testing Artificial Intelligence

2026 Biotech Watchlist IBRX, PACB, IGC, VIVS Lead 7 Stocks in Focus

October 01, 2026

Via AB Newswire

2026 Nanocap Stocks to Watch: IGC, KNRX, GYGY, ARAY Lead Watchlist Now See More Inside!

September 28, 2026

Via AB Newswire

Topics Artificial Intelligence

VivoSim Labs Inc. (NASDAQ: VIVS) Targets the Multibillion-Dollar Cost of Failed Drugs

September 28, 2026

Via AB Newswire

IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026

September 28, 2026

From IGC Pharma, Inc.

Via ACCESS Newswire

Greenland Stocks in Focus: GLND, GRML, CRML Lead the Watchlist More Names Inside

September 21, 2026

Via AB Newswire

Topics Government

VivoSim Labs Inc. (NASDAQ: VIVS) Takes Aim at Pharma’s 92% Drug-Failure Problem

September 21, 2026

Via AB Newswire

Topics Animal Testing

PullBack Stocks PDSB, PRSO, IGC, RETO: Who Breaks First?

September 15, 2026

Via AB Newswire

Topics Artificial Intelligence

IGC Pharma (NYSE: IGC) Target Raised on Alzheimer’s 2027 Outlook

September 01, 2026

Via AB Newswire

Topics Artificial Intelligence

Nasdaq 30’s VIVS, IGC, RIME, AIXI Stocks Now

August 26, 2026

Via AB Newswire

Topics Artificial Intelligence

MicroCaps IGC, BIVI, ORBS, RIME Sub-$1 Stocks to Watch Now

August 20, 2026

Via AB Newswire

Topics Artificial Intelligence

VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum

August 17, 2026

Via AB Newswire

Topics Animal Testing Artificial Intelligence

IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure

August 17, 2026

From IGC Pharma, Inc.

Via ACCESS Newswire

Microcaps TOON, IGC, SURG, MDXH to Watch Now as Earnings, AI and Biotech Catalysts Build

August 14, 2026

Via AB Newswire

Topics Artificial Intelligence Intellectual Property

VivoSim Labs (NASDAQ: VIVS) Emerges in Drug Toxicity Market as Revenue Growth Guidance Tops 500% – Plus More In Focus

August 14, 2026

Via AB Newswire

Topics Animal Testing Artificial Intelligence

Kartoon Studios (NYSE: TOON) Enters Next Growth Phase; Reports Q2 Revenue of $5.82M, EPS of $0.38 and $40.5M Cash Position – Plus More in Focus

August 14, 2026

Via AB Newswire

Topics Intellectual Property

Kartoon Studios (NYSE: TOON) Signs Amazon Prime Deal for “Hundred Acre Wood” Streaming Launch

August 13, 2026

Via AB Newswire

Topics Artificial Intelligence Intellectual Property

Early Alert: PLAG, PRSO, UZX, IGC Lead Sub-$1 Stocks to Watch – Plus More in Focus

August 11, 2026

Via AB Newswire

Topics Artificial Intelligence

IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline Readout

August 11, 2026

From IGC Pharma, Inc.

Via ACCESS Newswire

New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results

August 08, 2026

From New to The Street

Via ACCESS Newswire

Bullish Volume: RITR, IGC, BJDX, CISS Lead Active Sub-$1 Stocks to Watch

August 05, 2026

Via AB Newswire

Topics Artificial Intelligence Economy Fraud

Microcaps MGRX, PRSO, IGC, KUST In the News to Watch

July 31, 2026

Via AB Newswire

Topics Artificial Intelligence Energy Fraud

IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign

July 29, 2026

From IGC Pharma, Inc.

Via ACCESS Newswire

Undervalued Stocks in Focus: IGC, CISS, TOON, GOSS, KIDZ Enter Catalyst-Rich Growth Phase

July 28, 2026

Via AB Newswire

Topics Artificial Intelligence

New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)

July 18, 2026

From New to The Street

Via ACCESS Newswire

IGC Pharma (NYSE: IGC) Showcasing 7 AI Breakthroughs Advancing Alzheimer’s Drug Discovery at AAIC 2026

July 13, 2026

Via AB Newswire

Topics Artificial Intelligence

IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow

July 09, 2026

From IGC Pharma, Inc.

Via ACCESS Newswire

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.